ReleVote

Finn Sawyer Access to Cancer Testing Act

Bill Number
H.R. 1620
Origin Chamber
House
Congress
119th Congress, Session 1
Policy Area
Health
Status
Introduced
Latest Action
2025-02-26: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Last Updated
2025-12-05T21:51:33Z

Official Summary

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Sponsor

Rep. Matsui, Doris O. [D-CA-7]

Cosponsors (13)

Rep. Bilirakis, Gus M. [R-FL-12], Rep. Thompson, Mike [D-CA-4], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Bacon, Don [R-NE-2], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Landsman, Greg [D-OH-1], Rep. Himes, James A. [D-CT-4], Rep. Tlaib, Rashida [D-MI-12], Rep. Sewell, Terri A. [D-AL-7], Rep. Davis, Donald G. [D-NC-1], Rep. Gottheimer, Josh [D-NJ-5], Rep. Tonko, Paul [D-NY-20], Rep. Pingree, Chellie [D-ME-1]

Recent Actions

Bill Versions

Related Bills